Economic burden of varicella complications in two referral centers in Mexico

ABSTRACT Varicella-zoster virus causes varicella (chicken-pox), mainly in young children. Most cases are mild but serious complications can occur, resulting in significant morbidity and mortality. The objective of this study was to estimate the cost burden of varicella hospitalizations in two pediatric reference hospitals in Mexico. This retrospective observational study collected data on patients aged <18 years admitted to two third-level referral hospitals in Mexico. Cases were identified from hospital records using International Classification of Diseases Ninth Revision (ICD-9) codes 052 Chickenpox, or Tenth Revision (ICD-10) codes B01 Varicella (chickenpox). Data on demographic and clinical characteristics and resource use were collected from hospital records. Costs for hospital stay and interventions were obtained from the Mexican Institute for Social Security for 2015 and updated to 2017 costs. A total of 172 hospitalized varicella clinically-confirmed cases and 121 varicella- contacts (with epidemiological linkage to a clinically-confirmed case) were included. Thirty eight of the 172 cases (22.0%) experienced complications. There were no deaths. The median duration of hospitalization was 12 days for cases and 23 days for contacts. The median hospitalization cost was MXN 82,572 (USD 4,434) per case, and MXN 89,453 (USD 4,804) per contact. Although considered a mild disease, varicella was associated with a substantial cost burden in two Mexican third-level referral hospitals.

[1]  F. A. Carvalho‐Costa,et al.  Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine. , 2016, Jornal de pediatria.

[2]  Ç. Aydoğmuş,et al.  Children Hospitalized for Varicella: Complications and Cost Burden. , 2013, Value in health regional issues.

[3]  M. Hacımustafaoğlu,et al.  The epidemiology and economic impact of varicella-related hospitalizations in Turkey from 2008 to 2010: a nationwide survey during the pre-vaccine era (VARICOMP study) , 2012, European Journal of Pediatrics.

[4]  N. Alvis-Guzman,et al.  Costos directos de varicela complicada en una población pediátrica de Colombia , 2011 .

[5]  U. Heininger,et al.  Varicella , 2006, The Lancet.

[6]  J. Carapetis,et al.  The burden and cost of hospitalised varicella and zoster in Australian children. , 2004, Vaccine.

[7]  X. Sáez-Llorens,et al.  Complicaciones y costos asociados a la varicela en niños inmunocompetentes , 2002 .

[8]  B. TamaraHirsch,et al.  Complicaciones en niños con varicela en cuatro hospitales de Santiago-Chile: espectro clínico y estimación de costos directos , 2001 .

[9]  N. Alvis-Guzmán,et al.  [Direct costs of complicated chicken pox in a Colombian pediatric population]. , 2011, Revista de salud publica.

[10]  X. Sáez-Llorens,et al.  [Complications and costs associated with chickenpox in immunocompetent children]. , 2002, Revista panamericana de salud publica = Pan American journal of public health.

[11]  C. Perret,et al.  [Complications in children with varicella in 4 hospitals in Santiago, Chile: clinical spectrum and estimation of direct costs]. , 2001, Revista medica de Chile.